NFKBIA and hepatocellular carcinoma: Evidence of this is that, although our shRNA knockdown of NFKBIA resulted in only a 20% reduced expression in BT-549 and a 31% reduction in HCC-1806 compared to control scrambled, we were able to observe a significant decrease in sensitivity to selinexor in knockdown models.